Coronavirus channel feed

Eu­ro­pean Com­mis­sion to re­ceive few­er Pfiz­er-BioN­Tech vac­cine dos­es un­der amend­ed con­tract

2 weeks ago
Pharma

More than a year af­ter its emer­gency au­tho­riza­tion, FDA ful­ly ap­proves Pfiz­er's Covid pill Paxlovid for adults

3 weeks ago
FDA+

No­vavax lays off hun­dreds of em­ploy­ees as new CEO goes in­to res­cue mode

Last month
People

Enan­ta is look­ing for a part­ner on its Covid pill af­ter a PhII study dis­ap­points

Last month

Covid-19 pub­lic health emer­gen­cies are end­ing. What's chang­ing?

Last month
Pharma

Covid drug and vac­cine sales nose­dive, dent­ing bio­phar­ma rev­enue across the board

Last month
Pharma

For­mer Covid test­ing czar dish­es on the pol­i­tics that in­ter­rupt­ed the ear­ly pan­dem­ic re­sponse

Last month

South Dako­ta-based Covid-19 trans­genic cow an­ti­body start­up claims its first PhI­II win

Last month
R&D

FDA sim­pli­fies Covid-19 bi­va­lent vac­ci­na­tion process ahead of June ad­comm

Last month
Pharma
FDA+

In­flaRx wins FDA emer­gency use au­tho­riza­tion for Covid an­ti­body

2 months ago
Pharma
FDA+

Biotech launched dur­ing Covid — for Covid — looks for strate­gic al­ter­na­tives af­ter an­tivi­ral fails PhII tri­al

2 months ago
R&D

Brii Bio­sciences stops man­u­fac­tur­ing Covid-19 an­ti­body com­bo, plans to with­draw EUA re­quest

2 months ago
R&D
China

Mod­er­na CEO de­fends Covid-19 vac­cine price change at Sen­ate com­mit­tee grilling

2 months ago

Biden signs law re­quir­ing more de­clas­si­fi­ca­tions on Covid-19's ori­gins

2 months ago

Oral vac­cine play­er lays off 27% of staff as it shelves Covid work

2 months ago
People

Ahead of ad­comm for full ap­proval, FDA es­ti­mates Pfiz­er's Covid pill could save 1,500 lives per week

2 months ago
FDA+

Mer­ck asks EMA to reeval­u­ate re­ject­ed Covid-19 an­tivi­ral

2 months ago
FDA+

FDA will phase out 22 Covid-19 guid­ance doc­u­ments as emer­gency de­c­la­ra­tion ex­pires

3 months ago
Pharma
FDA+

Con­gress moves bill re­quir­ing de­clas­si­fi­ca­tion of Covid-19 ori­gins in­fo to Biden's desk

3 months ago

FDA re­jects Covid-19 drug over un­cer­tain­ties around small tri­al

3 months ago
FDA+

Eu­ro­pean reg­u­la­tors rec­om­mend re­jec­tion of Mer­ck’s Covid-19 drug mol­nupi­ravir

3 months ago
Pharma

Pfiz­er's Paxlovid gets March FDA ad­vi­so­ry meet­ing to dis­cuss full ap­proval

3 months ago
Pharma

Pfiz­er and BioN­Tech file BLA for Omi­cron-tar­get­ing Covid-19 vac­cine

3 months ago
FDA+

Mer­ck falls short in PhI­II Covid-19 pro­phy­lax­is tri­al, join­ing Pfiz­er

3 months ago
R&D
1234 Next page Last page
A service from the Financial Times